0% READ
FULL TEXT
INTRODUCTION
Traditional medicine is a holistic approach to health, focusing on the overall condition of the individual rather than the specific ailment or disease. It has a history of over 3000 years and is influenced by various conditions, environments, and geographic areas. Over the past 100 years, the development and mass production of chemically synthesized drugs have revolutionized health care in most parts of the world. However, large portions of the population in developing countries still depend on traditional practitioners and herbal medicines for primary care. Herbs and plants can be processed into various forms like whole herbs, teas, syrups, essential oils, ointments, rubs, capsules, and tablets. Extracts vary in solvent, temperature, and time, and components may vary significantly between batches and producers. There is no standardization (Benzie and Wachtel-Galor, 2011).
Herbs are recognized for their medicinal value and therapeutic benefits, as they contain pharmacologically active compounds from various plant parts that can act as life-saving drugs directly or indirectly. Plants and their constituents have long been harnessed for their flavors, scents, and therapeutic properties, offering a myriad of benefits over pharmaceutical products. Plant extracts and phytoconstituents have demonstrated diverse biological activities, including antihyperlipidemic, antidiabetic, anti-inflammatory effects, and free-radical scavenging (Zhang et al., 2015). Nature's balanced system promotes healthy life, with plants being a valuable source for drug discovery, particularly compounds with antioxidant activity, gaining attention in recent decades of the plant kingdom, which comprises approximately 374,000 known and accepted plant species, including about 308,312 vascular plants and 295,383 flowering plants (angiosperms), the angiosperms alone represent an immense reservoir of biological and medicinal potential (Christenhusz and Byng, 2016). Plants are rich in compounds, including secondary metabolites and aromatic substances, including phenols and tannins. These compounds have antioxidant properties and are important for pharmacological research and drug development. The first pharmacologically active pure compound, morphine, was produced from opium extracted from the seed pods of the poppy Papaver somniferum 200 years ago. Products from plants and natural resources have contributed significantly to commercial drug preparations today. Examples include digoxin, salicylic acid, reserpine, antimalarials, and lipid-lowering agents. Over 60% of cancer therapeutics on the market or in testing are based on natural products, with over 70% based on natural products or mimetics. About 25% of drugs prescribed worldwide are derived from plants, and 121 active compounds are in use (Wachtel-Galor and Benzie, 2011). Plants contain a variety of secondary metabolites, known as phytochemicals, which have diverse structural and functional properties. These metabolites, such as alkaloids, polyphenols, flavonoids, saponins, carotenoids, and terpenes, are biologically active molecules that play a vital role in the plant's secondary metabolism and promote health and disease prevention. Phytochemicals are produced by specific cellular types and carry out important functions in plant secondary metabolism, such as insect repellents, sun blockers, and growth regulators. However, their effects can depend on the dose (Rodríguez-Negrete et al., 2024). Researchers are exploring plant-based natural resources for potential drug development discoveries due to the increasing global demand for pharmaceutical substances.
Citrus fruits are one of the major sources of bioflavonoids plant secondary metabolites with potent antioxidant and pharmacological activities. These bioactive flavonoids, including hesperidin, naringin, diosmin, and tangeretin, have various pharmacological properties, including antioxidant, anti-inflammatory, cardioprotective, antimicrobial, and anticancer effects. Hesperidin, found in orange peels and pulp, has gained scientific interest for its potential role in chronic disease prevention and treatment (Barreca et al., 2020). As demand for safer, natural therapeutic agents increases, citrus-derived flavonoids are becoming prominent candidates in pharmacological research and drug development. Despite growing interest and expanding literature on hesperidin, a comprehensive understanding of its pharmacological mechanisms, therapeutic range, and bioavailability challenges remains limited. Hence, the present review aims to provide a comprehensive overview of the biological significance of hesperidin, a prominent citrus bioflavonoid. It focuses on elucidating its pharmacological activities, including antioxidants, anti-inflammatory, antimicrobial, anticancer, cardioprotective, neuroprotective, and metabolic effects.
ROLE OF BIOFLAVONOIDS IN DISEASE MANAGEMENT
Bioflavonoids are a class of natural benzo-γ-pyran derivatives found in fruits and vegetables. Bioflavonoids include flavonol (e.g., quercetin, myricetin), isoflavone (e.g., genistein, daidzein), flavan-3-ols (e.g., catechin, epigallocatechin), flavonone (e.g., naringenin, hesperidin), anthocyanidin (e.g., cynidin), etc. (Ghosh et al., 2022). Flavonoids, a remarkable group of polyphenolic substances, comprise over 6000 different components found in almost all plants and are responsible for the vibrant pigmentation of fruits (Panche et al., 2016). It is a subset of flavonoids which has been extensively utilized in alternative medicine to enhance various physiological functions (David et al., 2016). Bioflavonoids have been employed in the management of a wide spectrum of conditions, angina, atherosclerosis, stress, asthma, rheumatoid arthritis, herpes, cancer, cataracts, emphysema, common cold, colitis, gingivitis, recurring ear infections, glaucoma, hemorrhoids, high cholesterol, high blood pressure, macular degeneration, lupus, menopause, and urinary tract infections (Fernandes et al., 2017; Kris-Etherton et al., 2002).
Bioflavonoids, with their anti-inflammatory properties, play a crucial role in human health by regulating inflammation and reducing the risk of respiratory and cardiovascular illnesses (Frei and Higdon, 2003). In vitro studies have demonstrated the antitumor activity of flavonoids, showcasing various anticancer abilities such as inhibiting cell growth and kinase activity, inducing apoptosis, suppressing the secretion of matrix metalloproteinases, and inhibiting tumor invasive behavior (Ren et al., 2003). Importantly, dietary flavonoids have been shown to possess antitumor capabilities. Even in high concentrations, flavonoids exhibit no signs of toxic effects (Wren et al., 2002).
CITRUS FLAVONOIDS
Epidemiological research has highlighted the multifaceted impact of citrus flavonoids on various activities, encompassing antioxidant, anti-carcinogenic, anti-inflammatory activities, and neuroprotective effects (Hajialyani et al., 2019). They are part of the polyphenol family. Major types include flavanones (e.g., hesperidin, naringin, eriocitrin, didymin), flavones (e.g., apigenin, luteolin, diosmin), and polymethoxylated flavones (e.g., tangeretin, nobiletin). Flavanones are the most abundant in citrus. Biological activities of a few citrus flavonoids are summarized in Table 1 (Bellik et al., 2012; Huwait and Mobashir, 2022; Madureira et al., 2023; Mas-Capdevila et al., 2020).
| Effect | Mechanism | Example |
|---|---|---|
| Antioxidant | Scavenges free radicals, protects lipids and DNA from oxidative stress | Hesperidin, Naringin (Madureira et al., 2023) |
| Anti-inflammatory | Reduces cytokine production (e.g., TNF-α, IL-6) and inhibits NF-κB signaling | Nobiletin, Luteolin (Bellik et al., 2012) |
| Cardioprotective | Improves lipid metabolism, reduces LDL oxidation, and enhances endothelial function | Hesperidin, Diosmin (Huwait and Mobashir, 2022; Mas-Capdevila et al., 2020) |
| Anticancer | Induces apoptosis and inhibits tumour growth in cell studies | Nobiletin, Tangeretin (Morley et al., 2007) |
| Antidiabetic | Enhances insulin sensitivity and glucose uptake | Naringin (Den Hartogh and Tsiani, 2019) |
| Neuroprotective | Protects against neuroinflammation and oxidative stress in brain tissues | Hesperidin, Nobiletin (Ho and Kuo, 2014) |
| Hepatoprotective | Reduces liver lipid accumulation and inflammation | Naringenin (Márquez-Quiroga et al., 2025) |
Chemistry of Citrus Flavonoid
Flavanones, which constitute a major and predominant class of flavonoids (Figure 1a), comprise approximately 350 aglycones and 100 glycosylated forms identified to date. Structurally, flavanones conform to the general flavonoid framework, featuring a flavan nucleus composed of aromatic rings A and B linked by a dihydropyrone ring (C). Distinguishing features of flavanones include the absence of a C2–C3 double bond, the presence of a chiral carbon atom at the C2 position, and the lack of substitution at the C3 position of the C ring. These structural distinctions differentiate flavanones (Figure 1b) from the other two classes of flavonoids found in Citrus, namely flavones and flavanols (Barreca et al., 2017).
The prevalent aglycones of citrus flavonoids include hesperetin, naringenin, eriodictyol, isosakuranetin, taxifolin, poncirin, neoeriocitrin, neohesperidin, didymin, and narirutin. This group encompasses various combinations with a sugar moiety bound to the aglycone hydroxyl groups through the formation of an O-glycosidic linkage, typically found at the C-7 position (A ring). The bound saccharides are commonly rutinose or neohesperidose moieties, both L-rhamnosyl-D-glucosyl derivatives. The former presents an α-1,6 interglycosidic linkage, while the latter features an α-1,2 interglycosidic bond (Barreca et al., 2016, 2017).
Flavonoids offer numerous health benefits, including antioxidants, free radical scavenging, anti-inflammatory, and cytoprotective properties. They play a crucial role in treating obesity, diabetes, and cardiovascular disease by preventing cell damage and oxidative stress. Flavonoids' chemical structure allows them to act as radical scavengers, oxygen quenchers, and hydrogen-donating antioxidants (Mahmoud et al., 2019).
HESPERIDIN
Hesperidin (C28H34O15) is a naturally occurring flavanone glycoside (bioflavonoid) abundant in citrus fruits. Hesperetin is the aglycone (non-glycosylated) form of hesperidin. Both hesperidin and hesperetin exhibit antioxidant and anti-inflammatory properties, but hesperidin is the most abundant form in citrus fruits. Hesperidin was first isolated in 1828 by French chemist M. Lebreton from the white inner layer of citrus peels, derived from the name "hesperidium", a fruit of a citrus plant (Tong et al., 2023). It was formerly known as ‘Vitamin P’ (Man et al., 2019). It appears as a crystalline powder that is light yellow in color, odorless and tasteless. It has a melting point of 258-262°C and a molecular weight of 610.6 g/mol. Hesperidin is highly soluble in pyridine, dimethylformamide, and sodium hydroxide solution, but slightly soluble in benzene and acetone. Its solubility in water is very low, requiring approx. 50 L of water to dissolve 1 g of hesperidin (PubChem [Internet], n.d.; Ma et al., 2024). Structurally, hesperidin comprises an aglycon (hesperitin or methyl eriodictyol) linked to rutinose (Figure 2a), making it a -7-rutinoside of hesperetin (Figure 2b). Neohesperidin, an isomer of hesperidin (Figure 2c), is present in bitter oranges (Citrus aurantium) (Aggarwal et al., 2020; Hajialyani et al., 2019).
Sources of Hesperidin
Hesperidin, abundant in citrus fruits such as lemon and others, has been identified not only in Citrus species but also in diverse plant families like Fabaceae (e.g., Cyclopia spp.), Betulaceae (e.g., Carpinus spp.), Lamiaceae (e.g., Mentha spp.), and Papilionaceae (e.g., Pterocarpus spp.). Hesperidin has also been found in the bark of Zanthoxylum avicennae and Zanthoxylum cuspidatum, occurs predominantly as neohesperidin in Cynara species, and is present among the chemical constituents of the roots of Acanthopanax setchuenensis (Devi et al., 2015).
Citrus fruits and their juices are rich sources of bioflavonoids, particularly flavanones such as hesperetin, naringenin, eriodictyol, and isosakuranetin, as well as their glycosides. These compounds occur at varying concentrations, typically ranging from approximately 180 to 740 mg/L depending on the Citrus species and cultivar, and contribute to a range of biological activities (Barreca et al., 2017). Hesperidin, a prominent bioflavonoid, is commonly found in plants belonging to the Rutaceae family, including Citrus species like Citrus sinensis, Citrus limon, Citrus aurantiifolia, as well as in plants from the Lamiaceae family, such as Mentha piperita. Hesperidin is abundant in clementine, sweet orange, mandarin orange, and lemon juices (39.9-20.5 mg/100 mL juice) (Addi et al., 2021). Hesperidin can constitute up to 14% of immature oranges (Johnston et al., 2014). Generally, the immature citrus fruits and the citrus peel contain a higher amount of hesperidin (Man et al., 2019).
BIOLOGICAL ACTIVITY
Antimicrobial
Flavonoids are secondary (non-essential) metabolites synthesized by numerous plants, where they function as defense compounds against a variety of threats, including toxins and microbial pathogens. While some flavonoids play a role in protecting the plant's roots from pathogens, they also exhibit potential health benefits for humans. Hesperetin, the aglycone of hesperidin, demonstrates antimicrobial activity (Choi and Lee, 2023). Although the exact mechanisms behind these antimicrobial properties are not fully understood, several processes, including the activation of the host immune system, interference with bacterial membranes, and disruption of microbial enzymes, have been investigated. In addition to their antimicrobial effects, hesperidin and hesperetin have been reported to offer protection against toxicity induced by various factors, with this protective capability extending to tissues and cells through their antioxidant and radical scavenging activities (Garg et al., 2001). The multifaceted nature of flavonoids highlights their significance in both plant defense mechanisms and potential contributions to human health.
Anticancer
Hesperidin has been identified as a compound capable of inducing apoptotic cell death in various cancer cells through both intrinsic and extrinsic pathways (Bartoszewski et al., 2014). In SNU-C4 colon cancer cells, hesperidin triggers specific intracellular death-receptor pathways, leading to DNA fragmentation and the formation of perinuclear apoptotic bodies. The apoptotic process is notably characterized by the up-regulation of Bax and Caspase-3 mRNA (Park et al., 2008). Similarly, the administration of hesperidin to SNU-668 Human Gastric cells induces apoptotic changes, including chromatin condensation, apoptotic morphology of cellular bodies, modulation of Bcl-2, and activation of Caspase 3. These findings suggest the potential utility of hesperidin in patients with gastric cancer (Devi et al., 2015; Deng et al., 2025).). Hesperidin's ability to induce apoptosis in cancer cells highlights its promising role in cancer research and potential therapeutic applications. Hesperidin has been shown to induce apoptosis and cell cycle arrest, thereby inhibiting cancer cell proliferation and contributing to the reversal of drug resistance. In addition, evidence suggests that hesperidin may play a promising role in suppressing tumor cell metastasis, angiogenesis, and chemoresistance (Aggarwal et al., 2020).
Cardioprotective Effects
In an in vitro experiment, hesperidin demonstrated its ability to prevent hypoxic injury in cardiomyocytes by activating the PI3K/Akt intracellular signaling pathway (Yin et al., 2017). Further studies on the cardioprotective effects of hesperetin in rodents, particularly in a doxorubicin-induced oxidative stress model, revealed significant outcomes. In rats, hesperetin displayed cardioprotective effects at dose levels of 25, 50, and 100 mg/kg by reducing malondialdehyde levels and oxidative stress, while concurrently increasing glutathione levels in animals administered with doxorubicin (Trivedi et al., 2011). These results highlight the potential therapeutic applications of hesperidin for cardiovascular health.
Hesperidin is also help in normalizing the blood glucose levels via hepatic glucose-regulating enzyme activities, serum insulin and adiponectin levels, as well as serum and hepatic lipid levels (Akiyama et al., 2009). Hesperidin exhibits lipid-lowering effects by reducing plasma levels of total cholesterol, low-density lipoprotein-cholesterol, very-low-density lipoprotein-cholesterol, triglycerides, free fatty acids and phospholipids, and increasing levels of high-density lipoprotein-cholesterol. It also possesses antiplatelet activity, helps in vasodilation as well and helps in lowering the leukocyte activation (Zanwar et al., 2014).
Anti-inflammatory
Hesperidin shows significant anti-inflammatory activity against carrageenan and dextran-induced rat paw edema and carrageenan pleurisy without causing side effects (Guardia et al., 2001). Diosmin and hesperidin, used in combination (90% diosmin and 10% hesperidin), are employed for the management of chronic venous insufficiency. This combination has been reported to inhibit the inflammatory process in hyperpermeability induced by ischemia, a characteristic of venous stasis. The protective effects of these flavonoids against inflammatory disorders have been demonstrated in both in vivo and in vitro studies, potentially through mechanisms such as mechanisms that include the inhibition of eicosanoid synthesis and/or antioxidant-mediated free radical scavenging. Diosmin and hesperidin appear to inhibit leukocyte attachment to the endothelial wall and subsequent migration of these cells into the interstitium (Awad et al., 2024; Gerges et al., 2022; Rutkowska et al., 2024). It was found that hesperidin has anti-inflammatory activity in the non-neuronal system due to the reduction of inflammatory mediators via reductions in proinflammatory cytokines through the nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κβ) pathway (Kim et al., 2019; Tejada et al., 2019).
Oxidative stress and inflammation are major contributors to numerous life-threatening diseases and are mitigated by the biological activities of hesperidin and hesperetin, particularly their antioxidant and anti-inflammatory effects. The antioxidant activity of these compounds extends beyond radical scavenging to enhance cellular protection through the ERK/Nrf2 signaling pathway. In vivo and in vitro studies have demonstrated the potential of hesperidin, its metabolites, and derivatives in reducing inflammatory targets and molecular markers associated with chronic inflammation (Parhiz et al., 2015). Hesperidin supplementation has been shown to alleviate edema, reducing swelling due to fluid accumulation in the lower extremities, and is associated with improved vascular health (Chen et al., 2010). Additionally, it helps address issues such as unusual capillary leakiness, pain in the extremities, causing aches, night leg cramps, and weakness (Y. Li et al., 2019; Parhiz et al., 2015).
Antioxidant Properties
Hesperidin has demonstrated significant antioxidant properties in both chemical and biological assays (Wilmsen et al., 2005). Hesperidin also acts as an antioxidant by restoring the deficits in the activity of antioxidant enzymes, including Glutathione Peroxidase (GPx), glutathione reductase, catalase, and Superoxide Dismutase (SOD), which are downregulated (Kim et al., 2019). Hesperidin exhibits strong antioxidant properties that play a vital role in protecting biological systems from oxidative stress. Oxidative stress results from an imbalance between the production of Reactive Oxygen Species (ROS) and the body’s antioxidant defense mechanisms, leading to cellular damage and the development of chronic diseases such as cardiovascular disorders, diabetes, cancer, and neurodegenerative conditions. Hesperidin exerts its antioxidant effects through multiple mechanisms (Table 2).
| Mechanism | Description | Biological Impact |
|---|---|---|
| Free radical scavenging | Hesperidin donates hydrogen atoms or electrons to neutralize reactive oxygen species (ROS) and reactive nitrogen species (RNS), including superoxide anions, hydroxyl radicals, and peroxynitrite. | Protects biomolecules from oxidative damage and cellular injury (Liu et al., 2023; Slika et al., 2022). |
| Metal ion chelation | Binds with transition metal ions such as Fe²⁺ and Cu²⁺, preventing their participation in Fenton-type reactions that generate free radicals. | Reduces metal-catalysed oxidative stress and lipid peroxidation (Abdullah et al., 2025; Famurewa et al., 2022). |
| Enhancement of antioxidant enzymes | Upregulates endogenous antioxidant enzymes such as SOD, CAT, and GPx. | Strengthens cellular antioxidant defense and detoxification capacity (Alizadeh et al., 2025; Jomova et al., 2024). |
| Inhibition of lipid peroxidation | Prevents peroxidative degradation of membrane lipids by scavenging lipid radicals. | Maintains cell membrane stability and integrity (Martínez-Noguera et al., 2019). |
| Regulation of signaling pathways | Modulates redox-sensitive transcription factors, especially the Nrf2/ARE pathway, enhancing the expression of antioxidant and cytoprotective genes. | Promotes long-term antioxidant defense and reduces oxidative-induced inflammation (Martínez-Noguera et al., 2021; Zhu et al., 2020). |
Neuroprotective Effects
Neurodegeneration is implicated in various neurological disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Factors such as the accumulation of abnormal proteins, mitochondrial dysfunction, neuroinflammation, and oxidative stress contribute to the pathophysiology of neurodegenerative diseases (E. J. Choi and Ahn, 2008). Hesperetin exhibits significant neuroprotective effects through its antioxidant, anti-inflammatory, and anti-apoptotic mechanisms. It effectively scavenges ROS and enhances endogenous antioxidant defenses such as SOD, catalase, and GPx, thereby reducing lipid peroxidation and oxidative neuronal damage (Wang et al., 2013). Hesperetin also exerts anti-inflammatory actions by suppressing the secretion of TNF-α, IL-6, and IL-1β; reducing inducible iNOS and COX-2 gene expression; inhibiting NF-κB phosphorylation; and blocking IκBα phosphorylation and degradation (Li et al., 2023; Ren et al., 2016). Hesperidin has demonstrated neuroprotective effects against neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and cadmium-induced neurodegeneration. In Alzheimer's disease models, hesperidin reduced oxidative stress and cognitive impairment by alleviating neuroinflammation mediated by TLR4. In Parkinson's disease models, hesperidin was effective in mitigating neuroinflammatory reactions and dopaminergic denervation, suggesting a significant potential as a neuroprotective agent. Hesperidin also aids in counteracting cadmium-induced neurotoxicity by activating antioxidant defenses without inducing apoptosis. Additionally, it exhibits antidepressant-like effects by modulating neuroinflammation associated with depressive behaviors, enhancing serotonergic activity, and increasing levels of BDNF (Li et al., 2023). Hesperetin also improves emotional memory and hippocampal long-term potentiation by enhancing AMPAR trafficking and balancing oxidants and antioxidants (Luo et al., 2021). Overall, hesperidin's multifaceted roles in neuroprotection and antidepressant activity warrant further investigation into its mechanisms and therapeutic applications.
Neurobehavioral Effects
Preclinical evaluation of hesperidin in Sprague Dawley rats demonstrates a favorable neurobehavioral and safety profile. Repeated oral administration of hesperidin (25-100 mg/kg) for 28 days produced no significant effects on locomotor activity, grip strength, memory performance, or body weight. However, higher doses were associated with improved anxiety-related behavior, indicating a potential anxiolytic effect. Importantly, key biochemical markers of hepatic and renal function, including AST, ALT, ALP, bilirubin, urea, and creatinine, remain unaltered (Selvam et al., 2023). Additionally, hesperidin has been shown to mitigate neurobehavioral deficits induced by environmental toxins, such as fluoride, including motor and memory impairments and depression-like behavior. Its protective effects are associated with improvements in brain biochemical markers and are suggested to involve PPAR-γ-mediated pathways, as inhibition of this receptor reduces hesperidin’s efficacy (Jaiswal et al., 2020). These findings suggest that hesperidin may enhance alertness and reduce anxiety without exerting adverse effects on systemic biochemical or organ function parameters, supporting its safety in preclinical models.
Antidiabetic Activity
Studies have demonstrated that hesperidin administration in diabetic models significantly reduces fasting blood glucose levels and food intake, while increasing serum and pancreatic insulin levels, pancreatic-duodenal homeobox-1 protein expression, and body weight (Hanchang et al., 2019). Hesperidin also exerts protective effects on pancreatic β-cells by enhancing the activities of antioxidant enzymes, including SOD and GPx, while reducing nitrotyrosine and malondialdehyde levels (Mallik et al., 2024; Mirzaei et al., 2023). Additionally, hesperidin treatment decreases the concentration of TNF-α and the expression of endoplasmic reticulum stress markers GRP78 and CHOP proteins in the pancreas of diabetic rats. Furthermore, hesperidin regulates the expressions of apoptosis-regulatory proteins, upregulating anti-apoptotic Bcl-xL while downregulating pro-apoptotic Bax and cleaved caspase-3, and inhibiting the activation of the DNA repair protein poly (ADP-ribose) Polymerase (PARP) (Hanchang et al., 2019). Hesperetin has also shown efficacy against hyperlipidemia and hyperglycemia and prevents diabetes-induced histological changes in the liver and kidney (Jayaraman et al., 2018). Furthermore, it effectively reduces blood glucose levels and normalizes hepatic and renal biochemical markers (Parasuraman and Thinagaran, 2023). Mechanisms of antidiabetic activity of hesperidin are summarized in Table 3.
| Pathway | Effect of hesperidin |
|---|---|
| Glucose metabolism and enzyme regulation | Increase the activity of hexokinase and glucose-6-phosphate dehydrogenase (Sundaram et al., 2019).Decrease the activity of gluconeogenic enzymes like glucose-6-phosphatase and PEPCK (Mirzaei et al., 2023; Peng et al., 2021).Decrease glucose-6-phosphatase and fructose-1,6-bisphosphatase (Sundaram et al., 2019). |
| Insulin receptor signalling/insulin sensitivity | Enhancing the activity of glucokinase, inducing the phosphorylation of insulin receptor and phosphoinositide-dependent kinase 1 in the liver (Peng et al., 2021).Decreasing the activity of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase in the liver (Peng et al., 2021).Restore the functioning of hepatic glucose metabolic enzymes (Mirzaei et al., 2023). |
| Glucose uptake in peripheral tissues | Enhancement of glucose uptake in primary rat adipocytes and in skeletal muscle cell line (Peng et al., 2021) (Dhanya and Jayamurthy, 2020). |
| Antioxidant / anti-inflammatory effects | Increases the levels of antioxidant enzymes both in the bloodstream and the pancreas (Mirzaei et al., 2023).Reduces reactive oxygen species (ROS), increases antioxidant enzyme activities (SOD, CAT, glutathione, etc.) (Mahmoud et al., 2012).Decreases markers of inflammation (e.g. TNF-α, IL-6) (Mahmoud et al., 2012). |
| Inhibition of postprandial hyperglycemia | Inhibits α-glucosidase enzyme (Kaliaperumal et al., 2023). |
Dermatological Effect
Studies suggested that hesperidin supports proper cutaneous function, including wound healing, UV protection, anti-skin cancer effects, and skin lightening. It contributes to the homeostasis of epidermal permeability barrier through its antioxidant properties, inhibition of MAPK-dependent signaling pathways, and stimulation of epidermal proliferation, differentiation, and lipid production (Man et al., 2019).
Hepatoprotective Effect
Hesperidin can protect the liver from injury, which is caused by drugs such as diclofenac via antioxidant, anti-inflammatory, and antiapoptotic actions (Hassan et al., 2021). Hesperidin and neohesperidin dihydrochalcone have been found to reduce the formation of ulcers in cold-restraint ulcers, suggesting that the amount of gastric mucus is not involved in their antiulcer activity (Suárez et al., 1996). Both hesperidin and neohesperidin from bittersweet orange peels have been found to aggravate gastric damage caused by indomethacin administration, suggesting that they have proinflammatory properties in ulcerogenic stomach lining (Hamdan et al., 2014).
Gastroprotective Effects
The combination of lycopene and hesperidin has been shown to protect experimentally induced ulcers in laboratory rats. Lycopene, a carotenoid found in vegetables and fruits, showed substantial improvement in ulcer conditions when pretreated with both hesperidin and lycopene. However, a combination of lycopene and hesperidin showed more significant restoration of gastric function compared to sham-operated rats (Jain and Katti, 2015). Hesperidin has also been found to protect against stress-induced gastric ulcer in diabetic rats through the regulation of peroxisome proliferator-activated receptor gamma (Elshazly et al., 2018). In rats with chronic gastric ulcers induced by acetic acid, hesperidin accelerates the gastric healing process by stimulating the enzymatic activity of Glutathione-S-transferase in the gastric mucosa tissue by 35%, reducing the prevalence and severity of gastric ulcers. Hesperidin also normalises superoxide dismutase and catalase activities at similar levels compared to those in the non-ulcerated group (Silva et al., 2019).
Gonadoprotective Effects
Hesperidin has demonstrated significant protective effects against AlCl3-induced testicular toxicity in experimental animal models (Parasuraman et al., 2024; Yan et al., 2024). In a study conducted on male Sprague-Dawley rats, exposure to AlCl3 resulted in marked reproductive dysfunction, including oligospermia, structural alterations of the seminiferous tubules, and impaired testicular morphology. These adverse effects were accompanied by significant disturbances in liver and kidney function, indicating systemic toxicity. Administration of hesperidin at doses of 100 mg/kg and 200 mg/kg effectively mitigated AlCl3-induced biochemical, hematological, and histopathological alterations. Hesperidin treatment preserved normal testicular architecture, maintained seminiferous tubule integrity, and exhibited notable nephroprotective effects. The protective actions of hesperidin are largely attributed to its antioxidant properties, which counteract oxidative stress and cellular damage induced by aluminum exposure (Parasuraman et al., 2024).
Safety profile
In acute oral toxicity studies, hesperidin exhibited low toxicity, causing only 10% mortality at a high dose of 5000 mg/kg in Sprague-Dawley rats, with a calculated median lethal dose of 4837.5 mg/kg. Sub-chronic toxicity evaluation revealed that hesperidin administered orally at doses of 250 and 500 mg/kg did not produce any adverse effects on body weight, food intake, clinical signs, ophthalmological and neurological parameters, urinalysis, hematology, clinical biochemistry, organ weights, or gross pathology. However, at 1000 mg/kg, significant alterations were observed in body and organ weights, hematological and biochemical parameters, and tissue histopathology. Based on these findings, the LOAEL for hesperidin is determined to be 1000 mg/kg for both male and female rats, indicating a favorable safety profile at lower doses (Li et al., 2019).
Clinical Effectiveness of Hesperidin
Hesperidin has been the subject of numerous clinical trials investigating its effects across metabolic, cardiovascular, bone, cognitive, and immune-related conditions. In metabolic disorders, hesperidin has been shown to improve insulin sensitivity and glucose metabolism in patients with metabolic syndrome and prediabetes (NCT02610491, NCT03737422), with additional benefits observed when combined with flaxseed in non-alcoholic fatty liver disease and prediabetes (Maurer Sost et al., 2023; Yari et al., 2021). Cardiovascular and vascular studies indicate that diosmin/hesperidin combinations can reduce symptoms of chronic venous insufficiency, varicose veins, and support post-operative rehabilitation (NCT03471910, NCT06753448), while orange juice-derived hesperidin has been reported to enhance vascular compliance and endothelial function (NCT04731987, NCT04234100) (Bioavailability of Hesperidine and Narirutin From Orange Juice to Identify Metabotypes in Hypertension (FLAVOTIP); NCT No: NCT04234100, 2022; Girgin and Duman, 2025; Steinbruch et al., 2020; Verny et al., 2021). In postmenopausal women, hesperidin supplementation positively influences bone biomarkers and mineral density, suggesting potential benefits for osteoporosis management (NCT00330096) (Loukas et al., 2024). Hesperidin also appears to enhance exercise performance and endurance in athletes (NCT04597983) and may support cognitive function in the elderly when used alongside dietary supplements (NCT06352099) (Giovannini et al., 2026; Martínez Noguera et al., 2021; Martínez-Noguera et al., 2021). Safety and bioavailability studies indicate that hesperidin is generally well-tolerated, though its clinical efficacy can vary depending on the formulation and co-administration with other flavonoids (NCT05158192, NCT04234100) (Bioavailability of Hesperidine and Narirutin From Orange Juice to Identify Metabotypes in Hypertension (FLAVOTIP); NCT No: NCT04234100, 2022) (Bioavailability of Diosmin/Hesperidin (90/10) 500 Mg Tablets With Regards to Reference Product; NCT No: NCT05158192, 2022). Additionally, hesperidin has been explored in COVID-19 therapy in combination with diosmin, although results are largely unknown (NCT04452799), and in other conditions such as rheumatoid arthritis (Hesperidin and Diosmin for Treatment of COVID-19; NCT No: NCT04452799, 2020), Helicobacter pylori infection, hyperglycemia control, and dental pulp treatment. These findings highlight the multiple beneficial effects of hesperidin and support the need for further large-scale, controlled trials to clarify its therapeutic potential.
CONCLUSION
Hesperidin, a prominent citrus bioflavonoid, exhibits a broad spectrum of biological activities, including anti-inflammatory, antioxidant, antihypertensive, antimicrobial, anticarcinogenic, and vasodilator properties. It is used as a marketed drug and nutraceutical and has potential therapeutic applications in neurodegenerative disorders. The compound has been found to improve venous tone, enhance microcirculation, assist in the healing of venous ulcers, and is employed in the management of chronic venous insufficiency, haemorrhoids, and the prevention of postoperative thromboembolism. Its supplementation is associated with addressing issues like unusual capillary leakiness, pain in the extremities, causing aches, night leg cramps, and weakness. Collectively, these multifaceted benefits affirm hesperidin as a bioactive compound of considerable pharmacological and clinical relevance.
